BioCentury | May 3, 1999
Finance

Oh, Canada!

...by the Business Development Bank of Canada. Despite the activity, sellside analyst Cameron Groome at First Marathon...
...traditional biotech investors who have learned the 'dos and don'ts' of biotech investing," he said. First Marathon...
BioCentury | Feb 16, 1999
Finance

Britain's ray of sunshine

...to C$137 million (US$91 million) from HMR, including US$16 million in upfront monies plus royalties. First Marathon...
BioCentury | Jan 5, 1998
Finance

Stuck in very low gear

...the U.S. border, investors seem to have a bias towards companies with operating revenues, noted First Marathon...
BioCentury | Feb 24, 1997
Finance

Sap for the maple leaf

...had been done by government and venture capital is starting to bear some fruit," said First Marathon...
...had been done by government and venture capital is starting to bear some fruit," said First Marathon...
Items per page:
1 - 4 of 4
BioCentury | May 3, 1999
Finance

Oh, Canada!

...by the Business Development Bank of Canada. Despite the activity, sellside analyst Cameron Groome at First Marathon...
...traditional biotech investors who have learned the 'dos and don'ts' of biotech investing," he said. First Marathon...
BioCentury | Feb 16, 1999
Finance

Britain's ray of sunshine

...to C$137 million (US$91 million) from HMR, including US$16 million in upfront monies plus royalties. First Marathon...
BioCentury | Jan 5, 1998
Finance

Stuck in very low gear

...the U.S. border, investors seem to have a bias towards companies with operating revenues, noted First Marathon...
BioCentury | Feb 24, 1997
Finance

Sap for the maple leaf

...had been done by government and venture capital is starting to bear some fruit," said First Marathon...
...had been done by government and venture capital is starting to bear some fruit," said First Marathon...
Items per page:
1 - 4 of 4